250 likes | 399 Views
The Use of Comparative Effectiveness Research In Decision Making ~ Gail Shearer Consumers Union AHRQ 2007 Annual Conference September 27, 2007. Case study: How comparative-effectiveness research can benefit consumers and taxpayers.
E N D
The Use of Comparative Effectiveness Research In Decision Making ~ Gail Shearer Consumers Union AHRQ 2007 Annual Conference September 27, 2007
Case study: How comparative-effectiveness research can benefit consumers and taxpayers. • What made our project possible: Drug Effectiveness Review Project (OHSU; basis for Medicaid drug decisions by participating states) • Powerful model that can be expanded.
About Consumer Reports • Trusted source of objective information since 1936 • Accepts no advertising and is independent of all commercial interests including drug companies • Independent • Non-profit
Mission: • Provide unbiased in-depth information on prescription drugs for consumers and doctors • Increase access and affordability to needed medicines • Relieve financial burden caused by high drug prices
Goals for Consumers • Provide them with objective information on effectiveness of prescription drugs • Help them open a discussion about drug costs with their doctor • Help them afford the medicines they need (copayments, donut, uninsured)
Identifying CR Best Buy Drugs • Start with credible source of unbiased, rigorous analysis of clinical evidence about drug effectiveness (DERP) • Intense medical input through consultants, internal CU review, and medical peer review • Selections based on effectiveness, safety record, and price
Present Information in Easy to Use Format(back side of 2 page report)
The Statins • Introduction of generics: changing marketplace • Huge stakes: $8 billion for Medicare beneficiaries alone • Major health consequences of greater affordability
Possible Annual Savings: 5 Categories • Statins $1,300 (cholesterol) • Proton Pump Inhibitors: $2,000 (acid reflux and ulcers) • NSAIDs $2,200 (arthritis and pain) • Anti-depressants $1,200 • Beta Blockers $1,900 (high blood pressure)
Average Cost Plan Highest Cost Plan
Outreach and Intermediaries • Six states (GA, CA, AZ, MN, MD and PA) • Pharmacists, Doctors, Libraries, Senior groups, Employer and Employee Organizations • Recruit your doctor campaign • Agreement with Medco • Project with WEA Trust • Outreach to doctors through Tarascon
Early lessons from our outreach efforts: • Consumers have different needs • Need to work through trusted intermediaries • Importance of trustworthy sources • Learn more about how to communicate with consumers • Remember those without Internet access
WEA Insurance Trust • 2nd largest health insurer in Wisconsin (non profit, public education employees and families) • Conducted informational campaign directed to beneficiaries using Proton Pump Inhibitors (PPIs): -- sustained increase in market share of Prilosec OTC -- Individual out-of-pocket costs reduced $36,000 --$455,000 in savings to the Trust
Best Buy Drug Reports on Pocket Pharmacopoeia – PDA Reference
To: unbiased, evidence-based information